| NDC Code: |
53034-404 |
| Proprietary Name: |
Atovaquone and Proguanil Hydrochloride |
| Suffix: |
|
| Non-Proprietary Name: |
Atovaquone and Proguanil Hydrochloride |
| Dosage Form: |
TABLET, FILM COATED |
| Method: |
ORAL |
| Original Marketing Date: |
18-08-2011 |
| Category Name: |
ANDA |
| Application Number: |
ANDA091211 |
| Labeler: |
CLINICAL SOLUTIONS |
| Substance Name: |
ATOVAQUONE; PROGUANIL HYDROCHLORIDE |
| Active Numerator Strength: |
250; 100 |
| Active Ingredient Unit: |
mg/1; mg/1 |
| Pharm Classes: |
Antimalarial [EPC],Antiprotozoal [EPC],Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA] |
| DEA Schedule: |
|
